CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

CELZ Nasdaq CIK: 0001187953

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation NV
Business Address 211 E. OSBORN RD., PHOENIX, AZ, 85012
Mailing Address 211 E. OSBORN RD., PHOENIX, AZ, 85012
Phone 480-399-2822
Fiscal Year End 1231
EIN 870622284

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 20, 2026 View on SEC
8-K Current report of material events December 31, 2025 View on SEC
8-K Current report of material events December 19, 2025 View on SEC
S-3 Shelf registration for future offerings November 21, 2025 View on SEC
DEF 14A Definitive proxy statement November 13, 2025 View on SEC
8-K Current report of material events November 12, 2025 View on SEC
10-Q Quarterly financial report November 7, 2025 View on SEC
8-K Current report of material events October 31, 2025 View on SEC
DEF 14A Definitive proxy statement October 30, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment August 14, 2025 View on SEC

Annual Reports

10-K March 20, 2026
  • Received crucial FDA approvals for clinical trials for Type 1 Diabetes and chronic lower back pain, with patient recruitment underway.
  • Granted Orphan Drug Designation (ODD) for ImmCelz™ for Brittle Type 1 Diabetes, offering significant regulatory and commercial advantages.
View Analysis

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.